I131治疗病房设计指导.pdfVIP

NSW HOSPITAL AND UNIVERSITY RADIATION SAFETY OFFICERS GROUP (HURSOG) GUIDE TO RADIOIODINE THERAPY FACILITY DESIGN This document is a consensus statement produced by a working party of HURSOG, to aid in the design and construction of radioiodine therapy facilities (treatment rooms and radioactive waste tanks). The members of the working party were : Jocelyn Towson (Royal Prince Alfred Hospital), Richard Smart (St. George Hospital), Brenda Walker (Prince of Wales Hospital), Lee Collins (Westmead Hospital), and Mark Gilbert (post-graduate student, Uni. Western Sydney). Edit by chf. 1. Workload Data 1. The vast majority of treatments involve I131 - as iodide for thyroid carcinoma, with MIBG (for phaeochromocytoma), lipiodol (for hepatocellular carcinoma) and as iodide (for thyrotoxicosis) being less frequent uses. 1.2 Administered activity, typical workload and length of stay : Iodide 4-6 GBq (Ca) 1-4 per week 3 days 1 GBq (toxicosis) 5/year 6 days MIBG 8 GBq 1/year 6 days Lipiodol 1 GBq 10/year 3 days 1.3 Waste volume 80 litres /day/person, based on 10 litre flush, 8 flushes per day. NB. This does NOT include shower/handbasin waste - if this to be stored, then the volume per day will be much higher, and advice should be taken from the hydraulic engineers. 1.4 Activity discharged to sewage This can be calculated as the maximum activity present in a delay tank at any time using an assumption of 80% discharge over 3 days. The amount is less for toxic patients, but so is the administered activity. Usage Maximum Expected Tank Activity 1 room, 1 patient/week 2 x average administered activity